Prof. Andrew Levy


Research Area / Fields

  1. Prediction and prevention of diabetes related complications.
  2. Proof of concept for application of precision medicine to treat autism, intellectual disability.
  3. and drug resistant epilepsy.

Short Bio

Professor Levy received his BA Summa Cum Laude from Yale University in Molecular Biophysics and Biochemistry in 1982. He received a MSTP scholarship for his MD PHD training (1982-1990) at Johns Hopkins Medical School performing his PHD under Nobel Laureate Daniel Nathans working on the identification of a growth factor now known as Vascular Endothelial Growth Factor. He completed internal medicine residency at Johns Hopkins Hospital (1990-1992) and a cardiovascular fellowship at Brigham and Women’s Hospital at Harvard Medical School (1992-1996). He made Aliyah to the Technion in 1997 with his wife Nina and his children. Since 2009 he is a full tenured professor in the Technion. He has authored over 160 peer reviewed publications and successfully competed for grant support from NIH, JDRF, ISF, BSF and other international granting agencies.

Available Technologies for commercialization

arrow Business Development Contacts
Motti Koren
Director of Business Development, Life Sciences